Cancer Center For Blood Disorders

Bethesda, Maryland 20817

0 studies enrolling now · 3 studies all time

What they study most

Chronic Lymphocytic Leukemia, Follicular Lymphoma, MPN (Myeloproliferative Neoplasms), Marginal Zone Lymphoma, Non Hodgkin Lymphoma

Studies at this site

• A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL) — Stopped early
• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
• A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis — Stopped early